Track the 안국약품 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 안국약품 has recorded 17 public disclosures. The latest transaction was reported on 30 June 2026 (Other). Among the most active insiders: 어진. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
17 of 17 declarations
안국약품 is a South Korean company specializing in the manufacture of pharmaceutical products. It is listed on the XKRX market.